Lucid Diagnostics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
2024-11-13
Lucid Diagnostics Inc reports results for the quarter ended September 30 - Earnings Summary
  • Lucid Diagnostics Inc LUCD.OQ reported a quarterly adjusted loss of 25 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -34 cents. The mean expectation of six analysts for the quarter was for a loss of 22 cents per share. Wall Street expected results to range from -23 cents to -20 cents per share.

  • Revenue rose 49.7% to $1.17 million from a year ago; analysts expected $1.14 million.

  • Lucid Diagnostics Inc's reported EPS for the quarter was a loss of 25 cents​.

  • The company reported a quarterly loss of $12.37 million.

  • Lucid Diagnostics Inc shares had risen by 22.7% this quarter and lost 29.1% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 2.7% in the last three months.​

  • In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Lucid Diagnostics Inc is $3.00

This summary was machine generated from LSEG data November 13 at 03:27 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2024

-0.22

-0.25

Missed

Jun. 30 2024

-0.22

-0.23

Missed

Mar. 31 2024

-0.27

-0.40

Missed

Dec. 31 2023

-0.26

-0.25

Beat

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10